What Is Patient Blood Management?
Health authorities endorse an approach called patient blood management (PBM) to preserve and safeguard a patient’s own blood while promoting patient safety and empowerment.
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL Behring
CSL Plasma. Helping Those in Need Live Healthier Lives.
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 300 plasma collection centers in the U.S., Europe and China. The plasma collected is used by CSL Behring for the purpose of manufacturing and delivering its life-saving therapies to people in more than 100 countries.
More About CSL Plasma
CSL Seqirus. On the Front Line of Public Health Protection.
As the only vaccine company with a singular global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies, and the latest methods of production and distribution. Together with our partners we’re on the front line every day, working to help protect communities from seasonal influenza and global pandemic threats.
More About CSL Seqirus
CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
CSL is looking forward to attending the annual American Society of Hematology Annual Meeting. Stop by booth \#643 to learn more about our dynamic portfolio of lifesaving medicines. #ASH23 .
PRWeek recently interviewed CSL Chief Communications & Brand Officer Anthony Farina about his hybrid work routine, which includes a daily run. Learn more about today's work culture at CSL, driven by its promise to patients and public health. https://bit.ly/4aduM0Q
Congratulations to CSL Vice President Research, Dr Michael Wilson who has been appointed to the Research Australia Board with Professor Patricia Davidson, University of Wollongong Vice Chancellor and President. We’d also like to thank Dr Andrew Nash, our Chief Scientific Officer and Senior Vice President Research for his contributions to the Research Australia Board on behalf of CSL for the past 10 years. #CSL
At CSL, our dedication goes beyond innovation and solutions; it’s anchored in one fundamental value that shapes every decision we make. Explore careers at CSL: https://bit.ly/485D88D. #PromisingFutures #CSL
Chag Sameach! May the lights of Hanukkah brighten your home with love, light and joy. #Hanukkah
"I realized we had to do something," said Anthony Castaldo, CEO and Chairman of the Board of HAE International \(HAEi\) and of the U.S. Hereditary Angioedema Association \(HAEA\). During a recent town hall meeting with CSL employees, Castaldo, an HAE patient himself, described how motivated he felt to advocate for patients after his daughter also began experiencing symptoms of the rare condition hereditary angioedema \(HAE\). https://bit.ly/46KQqpZ
This weekend, the rare disease community suffered a terrible loss with the tragic passing of Vicki Modell. As the co-founder of the Jeffrey Modell Foundation, Vicki spent decades advocating on behalf of children and families impacted by primary immunodeficiency and through her tireless efforts countless numbers of people benefited from early diagnosis, access to treatments, patient support and much, much more. To the Modell family, we thank you for all you have done in support of this community and we send our deepest condolences for your loss.
"The partnerships are to become nuclei for innovation and thus for a sustainable innovation ecosystem in the Marburg and Central Hesse region with the aim of further improving the quality in the region together", says Dr. Lars Groenke, Managing Director of CSL's research and development department in Marburg, about the kick-off of the cross-mentoring program in Marburg. https://bit.ly/3N9B0F1
At CSL, we believe in the transformative power of community engagement. As we mark International Volunteer Day, we're proud to share that we ensure every employee can actively participate in community giving programs and volunteerism. Together, we contribute to local needs and foster a global spirit of service. #InternationalVolunteerDay
At CSL, helping to protect the public’s health is a top priority. According to the U.S. Centers for Disease Control and Prevention (CDC), getting a flu vaccine each year is the best way to help prevent potentially serious flu illness from spreading through your community. This U.S. National Influenza Vaccination Week, talk to your healthcare provider about the flu vaccine that’s right for you. Learn more about what we do: https://bit.ly/3Rrz3pU #CSLSeqirus #NIVW #influenza #CDC #DrivenByOurPromise #Flu #vaccination